Physician

Anna J Parchman, MD

According to 2025 Medicare claims, Anna Parchman, MD (NPI: 1578565321) practices family practice in the Hot Springs, AR market, with the plurality of this provider's patient population coming from Garland, AR. This provider's primary affiliated billing organization is HEALTHSTAR PHYSICIANS OF HOT SPRINGS, PLLC (NPI: 1376884692; TIN: 71-0836622) and primary practice location at 71913-8184. Parchman is affiliated with the AdvantagePoint Health Alliance - Hot Springs, LLC (ACO ID: A5037), participating under the MSSP model.

Parchman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 528 traditional Medicare patients, billed 14,698 HCPCS/CPT codes, and received $207,672 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 6,103 prescription claims across 383 beneficiaries totaling $726,275 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 148 claims. Open Payments data shows 115 records totaling $4,071. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $224,201 to $726,275. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $30,055 to $31,014.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	658	4,204	$156,377
2016	789	4,763	$180,985
2017	934	6,215	$211,373
2018	843	6,588	$236,387
2019	750	7,460	$255,570
2020	838	11,200	$287,257
2021	880	8,648	$178,633
2022	797	8,820	$166,870
2023	716	9,109	$161,884
2024	528	14,698	$207,672

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	343	4,063	$224,201
2016	375	5,026	$296,570
2017	425	5,515	$355,921
2018	401	5,566	$387,486
2019	374	5,435	$388,275
2020	363	5,386	$411,413
2021	352	5,584	$487,739
2022	376	5,252	$459,549
2023	377	6,093	$736,944
2024	383	6,103	$726,275

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	51	247	$13,075
2016	45	334	$10,910
2017	13	237	$5,189
2018	19	164	$4,535
2019	17	197	$6,142
2020	16	274	$8,201
2021	N/R	336	$19,190
2022	N/R	221	$15,328
2023	N/R	189	$19,120
2024	N/R	148	$27,061

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	201	201	$41
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	258	480	$40
G0444	Annual depression screening, 5 to 15 minutes	213	213	$17
80053	Blood test, comprehensive group of blood chemicals	195	263	$10
36415	Insertion of needle into vein for collection of blood sample	201	317	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	191	5,798	$212,928
Ozempic	Semaglutide	64	2,774	$82,737
Farxiga	Dapagliflozin Propanediol	81	3,760	$68,201
Jardiance	Empagliflozin	56	2,700	$52,148
Soliqua 100-33	Insulin Glargine/Lixisenatide	29	947	$20,011

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	59	$23,539
A7031	Face mask interface, replacement for full face mask, each	N	N/R	12	$1,085
A7030	Full face mask used with positive airway pressure device, each	N	N/R	11	$940
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	12	$673
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	13	$285

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	114	$2,080	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$1,991	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anna J. Parchman, MD?

Tedicare shows public-source Medicare data for Anna J. Parchman, MD (NPI 1578565321), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anna J. Parchman, MD have ACO affiliation data?

Anna J. Parchman, MD is shown with ACO affiliation data for AdvantagePoint Health Alliance - Hot Springs, LLC (MSSP, ACO ID A5037).

What billing organization is linked to Anna J. Parchman, MD?

Anna J. Parchman, MD is linked to HEALTHSTAR PHYSICIANS OF HOT SPRINGS, PLLC (billing NPI 1376884692) in the available physician profile data.

Does Anna J. Parchman, MD have Open Payments data?

Anna J. Parchman, MD has 115 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.